Last reviewed · How we verify
NCT06175585
Construction of Theoretical Model of Medical Treatment Behavior of Patients With Chronic Kidney Disease
trial testing narrative nursing in Narrative Nursing in 80 participants. Status unknown.
29 November 2024
Quick facts
| Lead sponsor | Shanxi Medical University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 29 November 2023 |
| Primary completion | 29 November 2024 |
| Estimated completion | 29 December 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- narrative nursing
- traditional nursing
Conditions studied
- Narrative Nursing — all drugs for Narrative Nursing →
- Maintenance Hemodialysis — all drugs for Maintenance Hemodialysis →
- Chronic Kidney Diseases — all drugs for Chronic Kidney Diseases →
Sponsor
Shanxi Medical University
Who can join
Adults 18 to 70, any sex, with Narrative Nursing or Maintenance Hemodialysis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The impact of narrative nursing interventions on negative emotions, self-efficacy, quality of life in individuals undergoing maintenance hemodialysis
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06175585
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Shanxi Medical University trials
Trials by the same sponsor.
- NCT06167668 — The Influence of Internet + Combined Family Empowerment Management Mode on Treatment Compliance of PATIENTS With CKD · unknown
- NCT05099757 — The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06175585 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanxi Medical University
- Last refreshed: 19 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06175585.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing